Nasus Pharma Ltd. Defensive Interval Ratio
Nasus Pharma Ltd. defensive interval ratio. Nasus Pharma Ltd. (NSRX) has a Defensive Interval Ratio of 515 days as of December 2025. Defensive assets of $3.05 Million (cash $-, short-term investments $3.05 Million, receivables $-) cover 515 days of daily cash needs of $5.93K/day. See NSRX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Nasus Pharma Ltd. (2024–2025)
Defensive interval ratio of Nasus Pharma Ltd. from 2024 to 2025. This chart shows how Nasus Pharma Ltd.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 515 days, meaning defensive assets of $3.05 Million can fund 515 days of operations without new revenue. Check Nasus Pharma Ltd. (NSRX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Nasus Pharma Ltd. Defensive Interval Ratio by Year (2024–2025)
Nasus Pharma Ltd. defensive interval ratio by year from 2024 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Nasus Pharma Ltd. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Nasus Pharma Ltd. (NSRX) total assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 515 days | $3.05 Million | $5.93K/day | $- | $3.05 Million | ▲ +515 days |
| 2024 | 0 days | $0.00 | $10.76K/day | $- | $0.00 | — |